Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

Sparse data bias: a problem hiding in plain sight

Sander Greenland, Mohammad Alì Mansournia, Douglas G. Altman · BMJ · 2016 · 877 citations · Full text

Public Health, Biostatistics, Causal Inference +16

The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata

James B. Spies · Obstetrics and Gynecology · 2002 · 633 citations

Medicine, Gynecology, Obstetrics +17

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Hugh S. Taylor, Linda C. Giudice, Bruce A. Lessey et al. · New England Journal of Medicine · 2017 · 493 citations · Full text

Medicine, Endocrinology, Gynecology +17

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Ayman Al‐Hendy, Andrea S. Lukes, Alfred N. Poindexter et al. · New England Journal of Medicine · 2021 · 201 citations · Full text

Medicine, Gynecology, Pharmacotherapy +17

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

William D. Schlaff, Ronald Ackerman, Ayman Al‐Hendy et al. · New England Journal of Medicine · 2020 · 200 citations

Medicine, Endocrinology, Gynecology +17